+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Mechanisms underlying δ- and μ-opioid receptor agonist-induced increases in extracellular dopamine level in the nucleus accumbens of freely moving rats



Mechanisms underlying δ- and μ-opioid receptor agonist-induced increases in extracellular dopamine level in the nucleus accumbens of freely moving rats



Journal of Oral Science 59(2): 195-200



The nucleus accumbens is a terminal area of the mesolimbic dopaminergic system that arises in the ventral tegmental area. Opioids are thought to enhance dopaminergic activity in the nucleus accumbens by activating δ- and μ-opioid receptors in the ventral tegmental area. However, δ- and μ-opioid receptor agonists increase extracellular levels of accumbal dopamine when infused directly into the nucleus accumbens of rats. Therefore, the roles of δ- and μ-opioid receptors in regulation of accumbal dopaminergic neural activity have been analyzed by using δ- and μ-opioid receptor ligands. This review describes the mechanisms underlying the stimulatory effects on accumbal dopamine efflux, which are induced by local administration of δ- and μ-opioid receptor agonists into the nucleus accumbens of freely moving rats. The focus of this article is neurochemical studies that use in vivo microdialysis techniques. Taken together, the in vivo neurochemical evidence from these studies indicates that δ- and μ-opioid receptor agonists increase accumbal dopamine efflux by activating naloxone-sensitive opioid receptors, and by mechanisms independent of naloxone-sensitive opioid receptors, in the nucleus accumbens.

(PDF emailed within 0-6 h: $19.90)

Accession: 059952948

Download citation: RISBibTeXText

PMID: 28637978

DOI: 10.2334/josnusd.16-0874


Related references

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neuroscience Letters 181(1-2): 57-60, 1994

The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Neuroscience 130(3): 745-755, 2004

Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats. Neuropharmacology 30(10): 1133-1136, 1991

Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis. European Journal of Pharmacology 385(1): 7-13, Nov 26, 1999

Effects of CCK-8 and of the CCK-B-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: A microdialysis study in freely moving rats. Brain Research 628(1-2): 254-262, 1993

Stimulation of accumbal GABAA receptors inhibits delta2-, but not delta1-, opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats. European Journal of Pharmacology 815: 18-25, 2017

Stimulation of accumbal GABAB receptors inhibits delta1- and delta2-opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats. European Journal of Pharmacology: -, 2018

Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens. Journal of Neuroscience Research 84(2): 450-459, 2006

Effect of the 5 ht2a receptor inverse agonist m100907 in combination with antipsychotic drugs on extracellular da levels in the prefrontal cortex and nucleus accumbens of freely moving rats. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 893 4, 2002

Effects of CCK-8 on extracellular dopamine metabolites in the posterior nucleus accumbens in freely moving rats. Japanese Journal of Physiology 44(SUPPL 1): S259, 1994

U69,593, a kappa opioid receptor agonist, decreases amphetamine-evoked extracellular dopamine levels in the nucleus accumbens of conscious rats. Society for Neuroscience Abstracts 23(1-2): 2145, 1997

Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats. Synapse 38(2): 167-176, 2000

Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats. Neuroscience Letters 138(1): 137-140, 1992

Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Research 765(1): 149-158, 1997

Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats increase in extracellular dopamine and serotonin. Brain Research Bulletin 19(6): 623-628, 1987